InSite Vision Incorporated is an ophthalmic product development company that offers ophthalmic pharmaceutical products. The Company's portfolio of products is based on its DuraSite sustained drug delivery technology. The Company's offerings include BromSite and DexaSite. DuraSite sustained drug delivery technology is a synthetic polymer-based formulation to extend the residence time of a drug relative to conventional topical therapies. DuraSite enables topical delivery of a drug as a solution, gel or suspension and can be customized for delivering a variety of drug candidates. The Company is engaged in the research and development and commercial support with the DuraSite drug delivery technology for the following topical products: AzaSite, Besivance, BromSite, DexaSite, AzaSite Plus and ISV-101.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:INSV
CUSIPN/A
Phone+1-510-8658800
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-1,693.11%
Return on EquityN/A
Return on Assets-608.13%
Miscellaneous
EmployeesN/A
Outstanding Shares131,950,000
Market Cap$45.85 million
Insite Vision (OTCMKTS:INSV) Frequently Asked Questions
What is Insite Vision's stock symbol?
Insite Vision trades on the OTCMKTS under the ticker symbol "INSV."
How were Insite Vision's earnings last quarter?
Insite Vision Inc. (OTCMKTS:INSV) released its quarterly earnings data on Tuesday, August, 11th. The company reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.03. The firm had revenue of $0.39 million for the quarter, compared to the consensus estimate of $0.32 million. View Insite Vision's Earnings History.
Has Insite Vision been receiving favorable news coverage?
Media coverage about INSV stock has been trending somewhat positive on Friday, Accern Sentiment reports. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Insite Vision earned a media and rumor sentiment score of 0.18 on Accern's scale. They also gave media coverage about the company an impact score of 46.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days. View Recent Headlines for Insite Vision.
How do I buy shares of Insite Vision?
Shares of INSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Insite Vision's stock price today?
One share of INSV stock can currently be purchased for approximately $0.3470.
How big of a company is Insite Vision?
Insite Vision has a market capitalization of $45.85 million.
How can I contact Insite Vision?
Insite Vision's mailing address is 965 ATLANTIC AVE, ALAMEDA, CA 94501, United States. The company can be reached via phone at +1-510-8658800.
MarketBeat Community Rating for Insite Vision (OTCMKTS INSV)
MarketBeat's community ratings are surveys of what our community members think about Insite Vision and other stocks. Vote "Outperform" if you believe INSV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSV will underperform the S&P 500 over the long term. You may vote once every thirty days.
